A Feasibility Study of the Effects of a Directed Exercise Program for Breast Cancer Patients Undergoing Chemotherapy with or without Radiation After Axillary Surgery
[Protocol 10-062] |
Heerdt, Alexandra, MD |
A Phase I Study of HER2/neu DNA Immunization for Patients with Metastatic or High-Risk Breast Cancer
[Protocol 04-101] |
Gilewski, Teresa, MD |
A Phase I-II Study of Dasatinib plus Paclitaxel in Patients with Metastatic Breast Cancer
[Protocol 08-122] |
Fornier, Monica, MD |
A Phase I/II Clinical Trial of Temsirolimus plus Neratinib for Patients with Metastatic HER2-Amplified or Triple-Negative Breast Cancer
[Protocol 10-005] |
Chandarlapaty, Sarat, MD, PhD |
A Phase I/II Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
[Protocol 10-039] |
Traina, Tiffany, MD |
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1
[Protocol 09-165] |
Keohan, Mary, MD |
A Phase IB Study of BKM120 plus MEK162 in Select Patients with Advanced Solid Tumors
[Protocol 11-117] |
Schwartz, Gary, MD |
A Phase Ib Study of Trastuzumab-MCC-DM1, Paclitaxel, and Pertuzumab in Patients with HER2-Positive, Locally Advanced or Metastatic Breast Cancer Who Previously Received Trastuzumab
[Protocol 09-093] |
Modi, Shanu, MD |
A Phase IB Study to Assess PTC299 plus Hormonal Therapy in Patients with Metastatic Breast Cancer
[Protocol 09-105] |
Dickler, Maura, MD |
A Phase II Study of Abraxane with or without Tigatuzumab in Patients with Metastatic Triple-Negative Breast Cancer
[Protocol 11-082] |
Traina, Tiffany, MD |
A Phase II Study of Adjuvant Bevacizumab, Metronomic Chemotherapy, Diet, and Exercise After Preoperative Chemotherapy for Breast Cancer
[Protocol 11-063] |
Dickler, Maura, MD |
A Phase II Study of Bicalutamide for the Treatment of Androgen-Receptor-Positive, Estrogen- and Progesterone-Receptor-Negative Metastatic Breast Cancer
[Protocol 07-022] |
Traina, Tiffany, MD |
A Phase II Study of Carboplatin and/or Bevacizumab Added to Neoadjuvant Paclitaxel Followed by Dose-Dense Doxorubicin/Cyclophosphamide in Triple-Negative Resectable Breast Cancer
[Protocol 10-056] |
Lake, Diana, MD |
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer
[Protocol 10-190] |
Traina, Tiffany, MD |
A Phase II Study of Paclitaxel, Trastuzumab, and Pertuzumab for the Treatment of Metastatic HER2-Positive Breast Cancer
[Protocol 10-142] |
Dang, Chau, MD |
A Phase II Study of Partial Breast Irradiation for Select Patients with Early Invasive or Noninvasive Breast Cancer
[Protocol 10-114] |
Powell, Simon, MD |
A Phase II Study of Repeat Breast-Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation for Local Recurrence of Breast Cancer
[Protocol 10-152] |
McCormick, Beryl, MD |
A Phase II Study of Tesetaxel as Initial Therapy for Patients with Metastatic Breast Cancer
[Protocol 10-197] |
Seidman, Andrew, MD |
A Phase III Study of Conventional Whole Breast Irradiation Versus Partial Breast Irradiation for Women with Early-Stage Breast Cancer
[Protocol 05-068] |
McCormick, Beryl, MD |
A Phase III Study of Paclitaxel plus Trastuzumab, Lapatinib, or Both as Neoadjuvant Treatment for HER2-Positive Breast Cancer
[Protocol 10-076] |
Dang, Chau, MD |
A Pilot Study of Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer Scheduled for Mastectomy
[Protocol 11-202] |
McArthur, Heather, MD |
A Pilot Study Surveying Female Cancer Patients' Preference for Sexual Health Interventions
[Protocol 10-034] |
Carter, Jeanne, PhD |
A Pilot Study to Identify Patient Factors Impacting Adherence to Oral Chemotherapy
[Protocol 11-194] |
Ginex, Pamela, RN, EDD |
A Prospective Analysis of Surgery in Patients Presenting with Stage IV Breast Cancer
[Protocol 09-056] |
King, Tari, MD |
A Prospective, Longitudinal Study to Examine Time-Dependent Neurocognitive Changes in Patients with Breast Cancer Receiving Adjuvant Chemotherapy
[Protocol 07-130] |
Ahles, Tim, PhD |
Clinical Significance of Germline BRCA Mutations
[Protocol 96-051] |
Offit, Kenneth, MD |
Clinical Study of McGhan Corporation-Style 410 Silicone-Filled Breast Implants
[Protocol 06-024] |
Disa, Joseph, MD |
Clinical Study to Assess Entry of Chemotherapeutic Agents into Brain Metastases in Women with Breast Cancer
[Protocol 09-109] |
Seidman, Andrew, MD |
Dual-Energy Contrast-Enhanced Digital Mammography for the Detection and Preoperative Staging of Breast Cancer
[Protocol 10-024] |
Jochelson, Maxine, MD |
EMPOWER Study: Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
[Protocol 10-104] |
Oeffinger, Kevin, MD |
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
[Protocol 10-071] |
Blinder, Victoria, MD |
Evaluating the Causes of Cancer in Young Patients
[Protocol 09-068] |
Stadler, Zsofia, MD |
Evaluating Treatment and Survivorship Care Plans within the LIVESTRONG(TM) Foundation Centers of Excellence Network: Phase II
[Protocol 11-155] |
McCabe, Mary, RN, MA |
Inamed Corporation-Style 410 Silicone-Filled Breast Implant Continued Assess Reconstruction/Revision Expansion (CARE) Clinical Study
[Protocol 06-076] |
Cordeiro, Peter, MD |
Measuring Patient Satisfaction in Breast Surgery: Development and Validation of a Patient-Reported Outcomes Instrument
[Protocol 05-058] |
Pusic, Andrea, MD, MHS |
Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer
[Protocol 06-163] |
Chandarlapaty, Sarat, MD, PhD |
Pilot Study of a Geriatric-Specific Psychoeducational Intervention for Elderly Cancer Patients
[Protocol 09-116] |
Roth, Andrew, MD |
Pilot Study of Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer Requiring Treatment of the Internal Mammary Lymph Nodes
[Protocol 10-025] |
Ho, Alice, MD |
Rehabilitation of Cognitive Changes in Breast Cancer Survivors
[Protocol 10-105] |
Ryan, Elizabeth, PhD |
Risk for Cognitive Decline in Older Women with Breast Cancer
[Protocol 10-079] |
Ahles, Tim, PhD |
Serum Estradiol Levels in Postmenopausal Women with Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
[Protocol 09-110] |
Castiel, Mercedes, MD |
